Showing results (31-40 of 920) with videos related to
Sort By:
Pageof 92
Acta Haematologica|January 1, 1984
Spontaneous platelet aggregation in heparin-treated patientsC Lecrubier, J Conard, M H Horellou, et al.Thrombosis and Haemostasis|July 1, 1997
Acute ischemic stroke and heparin treatmentsM M Samama, P C Desnoyers, J Conard, et al.Annales De Medecine Interne|January 1, 1995
[Association of dysfibrinogenemia and thrombosis. Apropos of a family (Fibrinogen Melun) and review of the literature]S Bentolila, M M Samama, J Conard, et al.Annales De Cardiologie Et D'Angeiologie|December 11, 2002
[Treatment of deep venous thrombosis by low molecular weight heparins. Comments on the recommendations of the North American Consensus]M M Samama, M H Horellou, J Conard, et al.Annales De Medecine Interne|January 1, 1986
[Resistance to vitamin K antagonists. 6 cases]J J Lefrère, F Guyon, M H Horellou, et al.Haemostasis|January 1, 1987
Laboratory monitoring of a low molecular weight heparin (enoxaparin) with a new clotting test (Heptest)L Bara, S Combe-Tamzali, J Conard, et al.Journal Des Maladies Vasculaires|January 1, 1987
[Biological modifications induced by 3 low molecular weight heparins, PK 10169, Kabi 2165 and CY 216, compared to unfractionated heparin injected subcutaneously in healthy subjects in general surgery and in aged subjects in internal medicine]L Bara, S Combe-Tamzali, J Conard, et al.Annals of Medicine|February 24, 2001
Heparin-induced thrombocytopenia: laboratory diagnosis and managementI Elalamy, C Lecrubier, M H Horellou, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|July 20, 1999
[Hereditary resistance to vitamin K antagonists. Apropos of a case]F Paganelli, J Conard, R Gelisse, et al.Journal Des Maladies Vasculaires|January 1, 1995
[Hemorrhagic complications of anti-vitamin K treatments]S Bentolila, S Radenne, M H Horellou, et al.Pageof 92